Monitoring intraocular pressure changes after intravitreal Ranibizumab injection using rebound tonometry

Ophthalmic and Physiological Optics

Volumn 34, Issue 4, 2014, Pages 438-444

  Fuest, Matthias ^a   Kotliar, Konstantin ^b   Walter, Peter ^b   Plange, Niklas ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b AACHEN UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Icare; Intraocular pressure; Intravitreal injection; Ranibizumab; Rebound tonometry

Indexed keywords

ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; RANIBIZUMAB;

AGED; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MALE; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; PATHOPHYSIOLOGY; PATIENT POSITIONING; PILOT STUDY; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PATIENT POSITIONING; PILOT PROJECTS; PROSPECTIVE STUDIES; RISK FACTORS; TONOMETRY, OCULAR;

EID: 84904675697     PISSN: 02755408     EISSN: 14751313     Source Type: Journal    
DOI: 10.1111/opo.12134     Document Type: Article

References (29)

1. Jager RD, Aiello LP, Patel SC & Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina 2004; 24: 676-698.
2. Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S & Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol 2007; 42: 807-811.
3. Aiello LP, Brucker AJ, Chang S et al. Evolving guidelines for intravitreous injections. Retina 2004; 24(5 Suppl): S3-S19.
4. Kontiola AI. A new induction-based impact method for measuring intraocular pressure. Acta Ophthalmol Scand 2000; 78: 142-145.
5. Kim JE, Mantravadi AV, Hur EY & Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 2008; 146: 930-934.e1.
6. Falkenstein IA, Cheng L & Freeman WR. Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin). Retina 2007; 27: 1044-1047.
7. Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N & Hillemeier J. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye (Lond) 2009; 23: 181-185.
8. Kotliar K, Maier M, Bauer S, Feucht N, Lohmann C & Lanzl I. Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model. Acta Ophthalmol Scand 2007; 85: 777-781.
9. Cacciamani A, Oddone F, Parravano M, Scarinci F, Di Nicola M & Lofoco G. Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length. Jpn J Ophthalmol 2013; 57: 63-67.
10. Friberg TR, Sanborn G & Weinreb RN. Intraocular and episcleral venous pressure increase during inverted posture. Am J Ophthalmol 1987; 103: 523-526.
11. Smith TJ & Lewis J. Effect of inverted body position intraocular pressure. Am J Ophthalmol 1985; 99: 617-618.
12. Dumskyj MJ, Mathias CJ, Dore CJ, Bleasdale-Barr K & Kohner EM. Postural variation in intraocular pressure in primary chronic autonomic failure. J Neurol 2002; 249: 712-718.
13. Singleton CD, Robertson D, Byrne DW & Joos KM. Effect of posture on blood and intraocular pressures in multiple system atrophy, pure autonomic failure, and baroreflex failure. Circulation 2003; 108: 2349-2354.
14. Stamer WD & Acott TS. Current understanding of conventional outflow dysfunction in glaucoma. Curr Opin Ophthalmol 2012; 23: 135-143.
15. Alm A & Nilsson SF. Uveoscleral outflow-a review. Exp Eye Res 2009; 88: 760-768.
16. Pallikaris IG, Kymionis GD, Ginis HS, Kounis GA & Tsilimbaris MK. Ocular rigidity in living human eyes. Invest Ophthalmol Vis Sci 2005; 46: 409-414.
17. Silver DM & Geyer O. Pressure-volume relation for the living human eye. Curr Eye Res 2000; 20: 115-120.
18. Eisenlohr JE, Langham ME & Maumenee AE. Manometric studies of the pressure-volume relationship in living and enucleated eyes of individual human subjects. Br J Ophthalmol 1962; 46: 536-548.
19. Schreiber W, Vorwerk CK, Langenbucher A, Behrens-Baumann W & Viestenz A. A comparison of rebound tonometry (ICare) with TonoPenXL and Goldmann applanation tonometry. Ophthalmologe 2007; 104: 299-304.
20. Rehnman JB & Martin L. Comparison of rebound and applanation tonometry in the management of patients treated for glaucoma or ocular hypertension. Ophthalmic Physiol Opt 2008; 28: 382-386.
21. Nakamura M, Darhad U, Tatsumi Y et al. Agreement of rebound tonometer in measuring intraocular pressure with three types of applanation tonometers. Am J Ophthalmol 2006; 142: 332-334.
22. Munkwitz S, Elkarmouty A, Hoffmann EM, Pfeiffer N & Thieme H. Comparison of the iCare rebound tonometer and the Goldmann applanation tonometer over a wide IOP range. Graefes Arch Clin Exp Ophthalmol 2008; 246: 875-879.
23. Salim S, Du H & Wan J. Comparison of intraocular pressure measurements and assessment of intraobserver and interobserver reproducibility with the portable ICare rebound tonometer and Goldmann applanation tonometer in glaucoma patients. J Glaucoma 2013; 22: 325-329.
24. Yamashita T, Miki A, Ieki Y, Kiryu J, Yaoeda K & Shirakashi M. Central and peripheral intraocular pressure measured by a rebound tonometer. Clin Ophthalmol 2011; 5: 1113-1118.
25. Dahlmann-Noor AH, Puertas R, Tabasa-Lim S et al. Comparison of handheld rebound tonometry with Goldmann applanation tonometry in children with glaucoma: a cohort study. BMJ open 2013; 3: e001788.
26. Pakrou N, Gray T, Mills R, Landers J & Craig J. Clinical comparison of the Icare tonometer and Goldmann applanation tonometry. J Glaucoma 2008; 17: 43-47.
27. Fuest M, Mamas N, Walter P & Plange N. Tonometry in corneal edema after cataract surgery: rebound versus goldmann applanation tonometry. Curr Eye Res 2014; doi:10.3109/02713683.2014.888451.
28. Nakakura S, Mori E, Yamamoto M, Tsushima Y, Tabuchi H & Kiuchi Y. Intradevice and interdevice agreement between a rebound tonometer, Icare PRO, and the tonopen XL and kowa hand-held applanation tonometer when used in the sitting and supine position. J Glaucoma 2013; doi:10.1097/ijg.0000000000000016.
29. Jablonski KS, Rosentreter A, Gaki S, Lappas A & Dietlein TS. Clinical use of a new position-independent rebound tonometer. J Glaucoma 2013; 22: 763-767.